Quest Diagnostics shareholders approve officer exculpation, elect directors at annual meeting

QUEST DIAGNOSTICS INC

Officer exculpation amendment approved with 80.2M for, 13.0M against; effective May 20, 2024.
All nine director nominees elected; vote totals ranged from 85.3M (Gary Pfeiffer) to 92.8M (Tracey Doi).
Advisory say-on-pay approved with 82.5M for, 10.6M against, 0.4M abstain.
Ratification of PricewaterhouseCoopers as auditor for 2024 approved with 96.5M for, 5.6M against.
Shareholder proposal on climate risk/science-based targets not approved; 39.1M for, 53.7M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.